DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr | ₹1,377 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,600 Cr |
Mar2023 | ₹1,824 Cr |
Mar2022 | ₹2,960 Cr |
Mar2021 | ₹1,984 Cr |
Mar2020 | ₹1,377 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | 44.15 | |
Mar2020 | ₹1,377 Cr | - |
Compare Profit After Tax of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹151,439.9 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,395.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
CIPLA | ₹119,252.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹101,889.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,191.9 Cr | -4% | -5.9% | -7.8% | Stock Analytics | |
MANKIND PHARMA | ₹94,909.6 Cr | -0.8% | -7.2% | 7.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.9% |
-0.3% |
63.8% |
SENSEX | -2% |
-2.3% |
2.5% |
You may also like the below Video Courses